
New Parkinson Disease Treatment
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
There is now another option for patients with Parkinson disease. The
In patients experiencing “off” episodes, safinamide has been shown in two clinical trials to be efficacious in reducing involuntary movement and improving motor function scores.
The most common side effects are falls, nausea, insomnia, and dyskinesia.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.